x
APPA
Productsace
Inquiryace

APPA

Inquiry

Cat. No.: DIA-0243321

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
CAS No. 100750-39-8
Formula C14H13NO3
Molecular Weight 243.26
SMILES CC(N1C(C2=CC=CC=C2)=CC(OC(C)=O)=C1)=O
Target Aldose Reductase, Apoptosis
Product Description APPA is an aldose reductase inhibitor. APPA can effectively prevent apoptosis and the symptoms of Streptozotocin (HY-13753)-induced diabetes by inhibiting the polyol pathway in rats. APPA has the potential for diabetic nephropathy (DN) research.
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
April
SunMonTueWedThuFriSat
303112345678910111213141516171819202122232425262728293012345678910
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
  • 1-516-880-2558
  • 500-A Wheeler Rd, Hauppauge, NY 11788, USA
Copyright © 2025 Ace Therapeutics. All Rights Reserved.
Top

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x